循经推按联合脂肝合剂对非酒精性脂肪性肝病患者肝脏硬度及脂肪衰减参数的影响
China's Naturopathy(2022)
Abstract
目的:探讨循经推按联合脂肝合剂对非酒精性脂肪性肝病(NAFLD)患者肝脏硬度及脂肪衰减参数的影响.方法:选取NAFLD患者63例,应用循经推按联合脂肝合剂治疗.治疗两周后,比较治疗前后患者的肝脏硬度、脂肪衰减指数变化.结果:治疗后,患者肝脏硬度、脂肪衰减指数均低于治疗前(P<0.05),但不同年龄、不同病程的患者肝脏硬度、脂肪衰减参数比较,差异均无统计学意义(P>0.05).结论:循经推按联合脂肝合剂治疗NAFLD,能显著改善肝脏病理状态及脂肪衰减程度.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined